Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Cash & Current Investments (2019 - 2025)

Historic Cash & Current Investments for IDEAYA Biosciences (IDYA) over the last 7 years, with Q3 2025 value amounting to $786.9 million.

  • IDEAYA Biosciences' Cash & Current Investments fell 1447.07% to $786.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $786.9 million, marking a year-over-year decrease of 1447.07%. This contributed to the annual value of $676.3 million for FY2024, which is 2879.47% up from last year.
  • Per IDEAYA Biosciences' latest filing, its Cash & Current Investments stood at $786.9 million for Q3 2025, which was down 1447.07% from $669.7 million recorded in Q2 2025.
  • Over the past 5 years, IDEAYA Biosciences' Cash & Current Investments peaked at $920.0 million during Q3 2024, and registered a low of $246.8 million during Q4 2021.
  • For the 5-year period, IDEAYA Biosciences' Cash & Current Investments averaged around $491.2 million, with its median value being $468.8 million (2023).
  • As far as peak fluctuations go, IDEAYA Biosciences' Cash & Current Investments soared by 24408.23% in 2021, and later crashed by 1644.68% in 2022.
  • Over the past 5 years, IDEAYA Biosciences' Cash & Current Investments (Quarter) stood at $246.8 million in 2021, then surged by 47.84% to $364.8 million in 2022, then skyrocketed by 43.93% to $525.1 million in 2023, then grew by 28.79% to $676.3 million in 2024, then grew by 16.35% to $786.9 million in 2025.
  • Its last three reported values are $786.9 million in Q3 2025, $669.7 million for Q2 2025, and $692.5 million during Q1 2025.